GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $80.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price increased by Morgan Stanley from $74.00 to $80.00 in a report published on Thursday morning,Benzinga reports. They currently have an equal weight rating on the stock.

A number of other equities analysts have also weighed in on GEHC. Barclays initiated coverage on GE HealthCare Technologies in a research note on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective on the stock. Evercore ISI boosted their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a report on Thursday. Zacks Research downgraded GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Finally, BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a report on Wednesday. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $86.10.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $74.95 on Thursday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.93. The business’s 50 day moving average price is $75.09 and its 200-day moving average price is $73.06. The firm has a market capitalization of $34.14 billion, a PE ratio of 15.49, a P/E/G ratio of 2.84 and a beta of 1.13. GE HealthCare Technologies has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities research analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

Institutional Investors Weigh In On GE HealthCare Technologies

Large investors have recently bought and sold shares of the stock. N.E.W. Advisory Services LLC acquired a new position in shares of GE HealthCare Technologies during the 1st quarter worth about $25,000. Allianz SE boosted its position in shares of GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. boosted its position in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after acquiring an additional 196 shares in the last quarter. Godsey & Gibb Inc. acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. Finally, Bogart Wealth LLC boosted its position in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.